Thalidomide gets a second chance in Japan
This article was originally published in Scrip
Executive Summary
An advisory committee to Japan's ministry of health, labour and welfarehas recommended the approval of thalidomide for the treatment of refractory multiple myeloma, providing a new opportunity to a product banned in the country in 1962.